Anti-STK17B Antibody
Boster Bio Anti-STK17B Antibody catalog # A08711-4. Tested in WB, IHC, ELISA. This antibody reacts with Human.
Product Specifications
Background
Serine/threonine kinase 17B (STK17B), also named as DRAK2, whose gene is located on chromosome 2 (2q32.3), was first reported by Sanjo et al. in 1998 (PMID: 9786912) . STK17B has been identified as a promising therapeutic target for type 1 diabetes, multiple sclerosis, and graft rejection. There are also some reports demonstrated that STK17B was related to apoptosis in various cell types, such as islet β-cells and acute myeloid leukemia cells. Some researches revealed that STK17B was deregulated in some cancers and have important role in cancer progression (PMID: 29445189) . It has an indispensable role in NAFLD/NASH and offer a potential therapeutic arget for this disease (PMID: 34614409) .
Gene Name
STK17B
UniProt
O94768
Host
Rabbit
Reactivity
Human
Immunogen
E.coli-derived human STK17B recombinant protein (Position: V252-D369) .
Clonality
Polyclonal
Applications
WB, IHC, ELISA
Purification
Immunogen affinity purified.
Concentration
500 μg/mL
Form
Liquid
Storage Conditions
12 months from date of receipt, -20°C as supplied. 6 months 2 to 8°C after reconstitution. Avoid repeated freezing and thawing.
Contents
500 μg/mL antibody with PBS,0.02% NaN3, 1 mg BSA and 50% glycerol.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
